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Abstract
Background: The growth and acceptance of osteopathic physicians as conventional medical
practitioners in the United States has also raised questions about the distinctive aspects of
osteopathic medicine. Although the use of osteopathic manipulative treatment (OMT) and a focus
on primary care are most often cited as rationales for the uniqueness of osteopathic medicine, an
osteopathic professional identity remains enigmatic.
Discussion:  The fledgling basic osteopathic research efforts of the early and mid-twentieth
century have not been sustained and expanded over time. Thus, there is presently a scarcity of basic
mechanistic and translational research that can be considered to be uniquely osteopathic. To be
sure, there have been advances in osteopathic clinical trials, particularly those involving OMT for
low back pain. Meta-analysis of these low back pain trials has provided evidence that: (1) OMT
affords greater pain reduction than active or placebo control treatments; (2) the effects of OMT
are comparable regardless of whether treatment is provided by fully-licensed osteopathic
physicians in the United States or by osteopaths in the United Kingdom; and (3) the effects of OMT
increase over time. However, much more clinical research remains to be done. The planning and
implementation of a large longitudinal study of the natural history and epidemiology of somatic
dysfunction, including an OMT component, represents a much-needed step forward. Osteopathic
medicine's use of OMT and its focus on primary care are not mutually exclusive aspects of its
uniqueness. The intersection of these fundamental aspects of osteopathic medicine suggests that
the profession may successfully adopt a generic strategy of "focused differentiation" to attain a
competitive advantage in the health care arena. While there are both requisite demands and risks
for the osteopathic profession in adopting such a strategy, these are reasonable in relation to the
potential rewards to be attained. To help promote an osteopathic identity, "omtology" and its
derivative terms are recommended in referring to the study of OMT.
Conclusion: The osteopathic profession should adopt a coherent strategy for developing and
promoting its identity. Failure to do so will likely ensure that osteopathic medicine remains "stuck
in the middle."
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Background
Osteopathy experienced substantial evolution and growth
during the twentieth century. The emergence and accept-
ance of osteopathic medicine as a "mainstream" or "con-
ventional" medical system appears to afford unparalleled
opportunities for the next generation of osteopathic phy-
sicians. Upon closer inspection, however, the triumphs of
osteopathic medicine and its position on the American
medical landscape may also herald a new challenge – that
for its long-term survival. Increasingly, osteopathic physi-
cians (DOs) are asked what makes them distinctive (i.e.,
different than allopathic physicians, or MDs). Inevitably
the responses focus on two rationales – the use of osteo-
pathic manipulative treatment (OMT) and an emphasis
on primary care. The objective of this commentary is to
review the history and current state of osteopathic
research, within the overarching framework of contempo-
rary medical practice with its emphasis on evidence-based
medicine and the "business" of medicine, and to offer
some suggestions on future directions for the osteopathic
profession.
Discussion
The present need for research on osteopathic 
manipulative treatment
A.T. Still established the osteopathic philosophy based on
anatomical and physiological principles. Prior to the rise
of the pharmaceuticals industry, the growth of osteopathy
was largely attributed to OMT and its presumed therapeu-
tic benefits. The licensure of osteopathic physicians in the
United States was de facto justification for OMT's place in
their clinical armamentarium prior to the emergence of
rigorous clinical trial methodologies.
However, several factors during the latter half of the twen-
tieth century altered this paradigm. First, the growth of the
pharmaceuticals industry and the regulatory need for
demonstrating the safety and efficacy of new drugs led to
the development of and reliance on randomized control-
led trials. Second, traditional epidemiologic research
methods developed for public health began to be applied
to clinical populations. Hastened by the growing power
and availability of computers, supporting software appli-
cations, and health-related databases, the field of clinical
epidemiology blossomed and subsequently refined the
tools for contemporary evidence-based medicine. Third,
with the requisite methodologies and resources to collect
and analyze clinical data widely available, government
and other third-party payers increasingly demanded evi-
dence not only of the safety and efficacy of clinical inter-
ventions, but also of their cost-effectiveness.
Consequently, in response to these phenomena, there is a
present need to demonstrate the safety, efficacy, and cost-
effectiveness of OMT.
Somatic dysfunction and its relationship to osteopathic 
manipulative treatment
Somatic dysfunction is defined as impaired or altered
function of related components of the somatic (body
framework) system: skeletal, arthrodial, and myofascial
structures, and related vascular, lymphatic, and neural ele-
ments [1]. Given the presence of somatic dysfunction and
its potential relationship to clinical or subclinical disease,
it is reasonable to hypothesize that OMT may be a useful
primary or complementary modality in a variety of clini-
cal entities encountered by osteopathic physicians.
The concept of somatic dysfunction raises some funda-
mental questions regarding its causal relationship to dis-
ease states and its responsiveness to OMT [2]. Is somatic
dysfunction  sufficient  to cause a particular disease? Is
somatic dysfunction necessary  to cause a particular dis-
ease? The most likely and complex scenario occurs when
the response to each of the previous questions is negative.
For example, when considering low back pain as the "dis-
ease," this scenario leads to the 2 × 2 table presented in
Figure 1. The following conclusions may thus be drawn:
(1) OMT may not be indicated for all patients with low
back pain; and (2) OMT may be useful in some patients
with somatic dysfunction, but without low back pain. The
first conclusion has important implications for establish-
ing inclusion and exclusion criteria when designing clini-
cal trials of OMT. The second conclusion suggests that
OMT may be useful as a secondary preventive measure.
The foregoing discussion highlights the need for research
on the natural history and epidemiology of somatic dys-
function. Relatively little research has been performed on
this integral aspect of osteopathic theory and practice. A
retrospective analysis of family medicine patients attend-
ing university-based clinics was recently performed to
begin addressing this issue [3]. This study measured the
burden of somatic dysfunction at various anatomical
regions as a function of prevalence and severity. As shown
in Figure 2, using cluster analysis, three distinct groups
emerged: (1) "high prevalence of somatic dysfunction";
(2) "low prevalence of somatic dysfunction"; and (3) "low
severity of somatic dysfunction." It should be emphasized
that the prevalence and severity of somatic dysfunction
and, consequently, the burden of somatic dysfunction
will vary with the methodological rigor and clinical pop-
ulation of a given study.
A large, long-term longitudinal study is urgently needed
to extend our knowledge in this fundamental area. Such a
study could not only address the natural history and epi-
demiology of somatic dysfunction, but also its response to
OMT. Following a baseline osteopathic examination, the
study would be facilitated by including a cohort of sub-
jects followed by osteopathic physicians and anotherOsteopathic Medicine and Primary Care 2007, 1:7 http://www.om-pc.com/content/1/1/7
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cohort followed by allopathic physicians. Because the lat-
ter do not diagnose or treat somatic dysfunction, the nat-
ural history of somatic dysfunction in the absence of OMT
could be ethically and validly studied. Additionally, ele-
gant case-control studies could be nested within this lon-
gitudinal design. The importance of this study to the
osteopathic profession would not be overstated by refer-
ring to it as the "Osteopathic Framingham Study."
Osteopathic manipulative treatment: the elephant in the 
room?
Some observers of osteopathic medicine criticize its con-
tinued promotion of OMT because of a perceived lack of
evidence regarding its efficacy. One point of view is that
belief in the efficacy of OMT is based more on faith than
on evidence [4]. Certainly, osteopathic physicians should
strive to demonstrate the efficacy of OMT using contem-
porary standards of evidence-based medicine whenever
possible. On the other hand, how many routinely
accepted non-pharmacological interventions, such as spe-
cific surgical procedures and psychotherapeutic interven-
tions, can boast of undisputed efficacy demonstrated
through large randomized controlled trials?
Important osteopathic clinical trials are being conducted
and planned. Sponsors of these clinical trials include the
National Institutes of Health, the Osteopathic Heritage
Foundations, and other organizations. For example, the
Osteopathic Research Center coordinates two major trials:
the Multi-Center Osteopathic Pneumonia Study in the
Elderly (MOPSE) (ClinicalTrials.gov identifier,
NCT00258661) and a large clinical trial of OMT for
chronic low back pain (ClinicalTrials.gov identifier,
NCT00315120). The Osteopathic Research Center hopes
The utility of osteopathic manipulative treatment (OMT) according to the potential relationships between somatic dysfunction  and low back pain (LBP) Figure 1
The utility of osteopathic manipulative treatment (OMT) according to the potential relationships between somatic dysfunction 
and low back pain (LBP).
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to soon begin enrolling subjects in two other clinical tri-
als. One trial involves the use of OMT for low back pain
in active duty military personnel, while the other entails
OMT to treat carpal tunnel syndrome. The Multi-center
Osteopathic Otitis Media Study (MOMS), which will
assess the efficacy of OMT for otitis media in children, is
presently at an advanced developmental stage.
The evidence for osteopathic manipulative treatment of 
low back pain
Not surprisingly, because of the historical preponderance
of low back pain as a reason for visiting osteopathic phy-
sicians, osteopathic clinical trials have addressed low back
pain more often than any other condition [5]. Thus, low
back pain may be viewed as the prototypical condition for
examining the present state of osteopathic clinical
research. In 1994, the Agency for Health Care Policy and
Research issued its far-reaching clinical practice guideline
on acute low back problems in adults [6]. The recommen-
dations on spinal manipulation are presented in Table 1.
It is important to note that these recommendations reflect
spinal manipulation generally, as practiced by a variety of
practitioners such as chiropractors and physical thera-
pists, and are not specific to osteopathic physicians. An
updated evaluation of this guideline in 2000 did not
report any important new evidence on spinal manipula-
tion [7]. Similar guidelines for the management of low
back pain in primary care have been developed interna-
tionally [8].
The clinical trials involving OMT for low back pain have
been published in such high-impact journals as The New
England Journal of Medicine [9], The Lancet [10], the Journal
of the American Medical Association [11], and Spine [12].
The three major osteopathic clinical trials involving low
back pain performed in the United States have been pre-
viously reviewed and summarized [13]. The overall results
of a recent systematic review and meta-analysis of OMT
for low back pain [5] are shown in Figure 3. The mean
effect size (ES) for OMT was -0.30 (95% confidence inter-
val [CI], -0.47 – -0.13; P = .001), indicating a statistically
significant and clinically important reduction in low back
The burden of somatic dysfunction as a function of prevalence and severity Figure 2
The burden of somatic dysfunction as a function of prevalence and severity. The anatomical regions are: C, cervical; H, head; L, 
lumbar; LLE, left lower extremity; LUE, left upper extremity; PI, pelvis/innominate; R, ribs; RLE, right lower extremity; RUE, 
right upper extremity; SP, sacrum/pelvis; T, thoracic.
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pain with OMT. A comprehensive series of subgroup and
sensitivity analyses were also performed as part of the
meta-analysis. These demonstrated that: (1) OMT pro-
vided greater pain reduction than active or placebo con-
trol treatments (ES, -0.26; 95% CI, -0.48 – -0.05; P = .02);
(2) the effects of OMT were comparable regardless of
whether treatment was provided by fully-licensed osteo-
pathic physicians in the United States (ES, -0.31; 95% CI,
-0.52 – -0.10; P = .004) or by osteopaths in the United
Kingdom (ES, -0.29; 95% CI, -0.58 – -0.00; P = .05); and
(3) the effects of OMT increased over time (ES, -0.28; 95%
CI, -0.51 – -0.06; P = .02 for short-term treatment [less
than one month]; ES, -0.33; 95% CI, -0.51 – -0.15; P <
.001 for intermediate-term treatment [one month to less
than three months]; ES, -0.40; 95% CI, -0.74 – -0.05; P =
.03 for long-term treatment [three months or longer]).
Several important implications derive from these find-
ings. The pain-reducing effects of OMT are significantly
greater than those of a placebo or sham treatment. In fact,
by comparison with published data, the pain reduction
afforded by OMT is comparable to that of non-steroidal
anti-inflammatory drugs, including cyclo-oxygenase-2
inhibitors [14], and may potentially last longer than these
drugs [15]. With the adverse events known to be associ-
ated with non-steroidal anti-inflammatory drugs, and
more intense scrutiny of the safety profile of cyclo-oxyge-
nase-2 inhibitors, OMT may offer an attractive alternative
to such drugs in many patients with low back pain, partic-
ularly those patients requiring ongoing treatment of
chronic pain. Finally, for planning purposes, it is impor-
tant to recognize that previous osteopathic clinical trials
have generally been inadequately powered to detect out-
comes at the threshold of clinical relevance.
Osteopathic enigmas
Webster's Thesaurus lists the following synonyms for the
term "enigma": puzzle, riddle, question, perplexity,
conundrum, mystery, secret, and hidden meaning. A clus-
ter of vaginal adenocarcinoma cases among young
women at a Boston hospital between 1966 and 1969 rep-
resented an enigma, as this type of cancer was rare and
unusual in young women [16]. No obvious causal factors
were originally identified. The resolution of this enigma
was facilitated by the deceptively simple consideration of
in-utero exposures among the cancer cases. A case-control
study then implicated maternal diethylstilbestrol (DES) as
the causal factor in subsequent development of vaginal
adenocarcinoma in the exposed daughters [16]. Some-
times the resolution of an enigma is much more complex,
as evidenced by the "Enigma machine" used by the Ger-
man military to encode secrets during World War II. The
basis for this enigma was the sheer number of possible
internal connections within the machine, far surpassing
the capability of any individual or small group to decode
the information. This enigma was overcome only by the
concerted efforts of many cryptanalysts working synergis-
tically with Allied forces throughout the war.
Osteopathic medicine has its enigmas as well. An enigma
integral to osteopathic principles involves the complex
inter-relationships among the spinal cord, autonomic
nervous system, and viscera. Louisa Burns performed ani-
mal research in this area in the early 1900s and was the
first osteopathic investigator to establish and carry on a
long-term research program [17]. J. Stedman Denslow
moved the field of osteopathic research forward in the
1940s at the Kirksville College of Osteopathy and Surgery,
where he also recruited many able investigators, including
Irvin Korr [17]. However, the clinical applications of such
research have materialized slowly over time and much
remains to be explored at present. The preliminary results
of case-control studies at the Osteopathic Research Center
have shown significant associations between osteopathic
palpatory findings and chronic diseases, including type 2
diabetes mellitus [18] and hypertension [19]. As with the
Table 1: Recommendations of the Agency for Health Care Policy and Research on spinal manipulation for low back problems in 
adults*
Recommendation Rating Level of evidence
Manipulation can be helpful for patients with acute low back problems without 
radiculopathy when used within the first month of symptoms.
B Moderate research-based evidence
When findings suggest progressive or severe neurologic deficits, an appropriate 
diagnostic assessment to rule out serious neurologic conditions is indicated before 
beginning manipulation therapy.
D Panel interpretation of information that did not 
meet inclusion criteria as research-based evidence
There is insufficient evidence to recommend manipulation for patients with 
radiculopathy.
C Limited research-based evidence
A trial of manipulation in patients without radiculopathy with symptoms longer than 
one month is probably safe, but efficacy is unproven.
C Limited research-based evidence
If manipulation has not resulted in symptomatic improvement that allows increased 
function after one month of treatment, manipulation therapy should be stopped and 
the patient re-evaluated.
D Panel interpretation of information that did not 
meet inclusion criteria as research-based evidence
*Based on reference 6Osteopathic Medicine and Primary Care 2007, 1:7 http://www.om-pc.com/content/1/1/7
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Enigma machine, resolution of such osteopathic enigmas
will require the concerted efforts of investigators dedi-
cated to basic mechanistic research and its translation into
clinical practice. Ominously, however, there appears to be
a dearth of basic investigators within the colleges of oste-
opathic medicine to respond to this research challenge.
Osteopathic medicine faces another enigma at a different
level – establishing a professional identity that is compat-
ible with the demands and expectations of contemporary
medical practice. In this regard, the osteopathic profession
may do well to adopt a generic strategy aimed at achieving
osteopathic "competitive advantage." As shown in Figure
4, the two-dimensional matrix used to select an appropri-
ate strategy involves a consideration of osteopathic medi-
cine's strategic advantage and its strategic target market
[20].
Some considerations in making conventional business
decisions involving the dimension of strategic advantage
may not apply directly to the health care market in the
United States. For example, the cost (i.e., price paid) for a
health care service may be largely constrained by third-
party payers who negotiate fixed fees. In such an environ-
ment, low cost leadership may not represent a viable strat-
egy. Even in the classical market situation, in which costs
are free to vary according to such factors as demand, cost
leadership does not represent a strategy to be embraced by
osteopathic physicians. Cost leadership implies large
economies of scale that are generally not seen in osteo-
pathic medical facilities and an "assembly-line" mentality
that is incompatible with the osteopathic "hands-on"
approach to patient care. Thus, it is clear that osteopathic
medicine must adopt perceived uniqueness as its mecha-
nism for strategic advantage.
Based on osteopathic principles and current specialty
practice patterns, few would argue against focusing on pri-
mary care as the appropriate strategic target market seg-
ment for osteopathic physicians. The relatively small
number of osteopathic physicians in non-primary care
specialties [21] effectively precludes successful targeting of
a health care industry-wide market and adoption of a pure
differentiation strategy. Consequently, the osteopathic
profession should adopt a "focused differentiation"
approach to positioning itself and competing within the
health care industry.
Implementing a focused differentiation strategy for 
osteopathic medicine
Implementing a focused differentiation strategy will entail
some challenges and potential risks for osteopathic medi-
cine. From an osteopathic professional perspective, there
are four basic requirements for implementing a focused
differentiation strategy [20]: (1) a long tradition within
the industry; (2) strong marketing abilities; (3) strong
capacity in basic research; and (4) ability to attract highly
skilled scientists, students, and creative people. Osteo-
pathic medicine has an established position on the Amer-
ican medical landscape; however, it has failed to
effectively market itself. Despite its potentially broad
appeal through a primary care focus and high levels of sat-
isfaction among established patients [22], only about half
of the United States population claims to be aware of oste-
opathic medicine [23]. As commented above, there is a
scarcity of basic scientists at the colleges of osteopathic
medicine who are able and willing to provide the profes-
Meta-analysis results for osteopathic manipulative treatment (OMT) of low back pain Figure 3
Meta-analysis results for osteopathic manipulative treatment (OMT) of low back pain. The overall effect size was -0.30 (95% 
confidence interval [CI], -0.47 – -0.13; P = .001). Source citations are available in reference 5.
Control No. of Subjects 
Source Treatment OMT Control Weight Effect Size (95% CI)
Hoehler 1981 Active and placebo 56 39 17
Gibson 1985 Active treatment 38 27 12
Gibson 1985 Placebo control 39 33 14
Cleary 1994 Placebo control 8 4 2
Andersson 1999 No treatment 83 72 29
Burton 2000 Active treatment 20 20 8
Licciardone 2003 Placebo control 32 19 9
Licciardone 2003 No treatment 42 17 9
Overall 318 231 100
-2.00 -1.00 0.00 1.00 2.00
Favors OMT Favors ControlOsteopathic Medicine and Primary Care 2007, 1:7 http://www.om-pc.com/content/1/1/7
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sion's much-needed research capacity. Appropriate incen-
tives are needed to attract such scientists, to support their
development and collaboration with clinical investiga-
tors, and to retain them over time. Additionally, the col-
leges of osteopathic medicine must seek to recruit highly-
qualified students who truly believe and adhere to osteo-
pathic philosophy. Two trends that make such student
recruitment problematic, at least presently, are the accel-
erating rate of establishment of new colleges of osteo-
pathic medicine and the increasing number of
osteopathic physicians entering residency programs
accredited by the Accreditation Council for Graduate
Medical Education (ACGME). Assuming a fixed, limited
number of highly qualified and desirable "osteopathi-
cally-oriented" applicants nationwide, expansion of the
colleges of osteopathic medicine will generally lead to a
dilution of such applicants with less optimal applicants.
The training of larger numbers of osteopathic medical
school graduates, particularly those of marginal osteo-
pathic orientation, in ACGME-accredited primary care res-
idency programs [24] may also have an inhibitory
influence on osteopathic philosophy and practices,
including OMT.
There are two potential risks for osteopathic medicine in
implementing a focused differentiation strategy [20]: (1)
differences between the market segments with respect to
health care services diminish over time and the health care
market as a whole converges; and (2) other health care
providers find submarkets within primary care and "out-
focus" osteopathic physicians. With advances in biotech-
nology and pharmaceuticals and an increasing proportion
of allopathic physicians entering subspecialty residency
programs [24], the risk of a convergence of the health care
market appears very low for the foreseeable future. The
risk of osteopathic physicians being "outfocused" is also
low at present, but may be potentially greater in the long
run. For example, if osteopathic physicians continue to
focus on primary care, but progressively abandon their
use of OMT (an aspect of their perceived uniqueness),
then complementary and alternative medicine (CAM)
practitioners, such as chiropractors, massage therapists,
and acupuncturists, may become more prominent first-
line providers for common primary care problems involv-
ing pain or musculoskeletal disorders. Similarly, integra-
tive medicine physicians, CAM practitioners, and other
non-physician clinicians may begin to encroach on tradi-
tional primary care boundaries. Overall, however, the
risks for osteopathic medicine in implementing a focused
differentiation strategy are low and are acceptable relative
to the potential advantages to be derived from such a strat-
egy. Failure to adopt a coherent strategy to develop and
Generic strategies for competitive advantage according to dimensions of strategic advantage and strategic target market Figure 4
Generic strategies for competitive advantage according to dimensions of strategic advantage and strategic target market.
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promote a professional identity will likely ensure that
osteopathic medicine remains "stuck in the middle" – a
poor strategic situation [20]. In response to this identity
challenge, I recommend using the term "omtology" to refer
to OMT-related research and scholarly activity. Similarly,
derivative terms such as "omtoepidemiology," "omtogenet-
ics," and "omtovigilance" may be used to refer to specific
fields of research within the realm of OMT.
Conclusion
The question of OMT efficacy is not the elephant in the
room. While much osteopathic research – mechanistic,
translational, and clinical – remains to be performed, the
clinical trials involving low back pain, taken together in a
meta-analysis, have provided evidence of OMT efficacy.
More importantly, the role of OMT and the emphasis on
primary care have not been adequately reconciled in
developing a professional identity for osteopathic medi-
cine. A focused differentiation strategy that entails both of
these aspects should be adopted by osteopathic medicine
to help develop and promote its professional identity.
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